AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 SEP 26 - (NewsRx.com & NewsRx.net) -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, announced that 70-90% of primary care physicians recently surveyed anticipate that their overall use of hormone replacement therapy (HRT) will decrease as a result of the conclusions reached by the Women's Health Initiative (WHI) and Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II) trials.
In sharp contrast to the primary care physicians surveyed in the latest PhysicianForum report, The Impact of the WHI and HERS II Trial Results on Hormone Replacement Therapy Management, thought- leading obstetrician/gynecologists indicate that they will make only moderate changes in their overall HRT management of patients.
"Our study indicates that since the unexpected findings of the WHI and HERS II trials were released, many primary care physicians will be quick to change HRT management of their patients," said Alice von Loesecke, senior director of research for PhysicianForum. "Primary care physicians surveyed said that they would modify their use of HRT based on the patient's uterine status. The change in management will be highest for patients with an intact uterus, as 67% of primary care physicians said they will significantly decrease the use of HRT in this patient population.
"Some of these patients will have their HRT discontinued immediately; others will remain on HRT until their duration of therapy reaches the time limit their physician considers to be safe."
The Impact of the WHI ...
Source: HighBeam Research, Physicians claim use of HRT will decrease due to controversial...